The UK has become the first to give legal approval to a new pill designed to treat COVID-19. With more than 104 million doses of the vaccine administered in the UK, with an estimated 45.8 fully vaccinated, the country is still experiencing a massive spike in cases. Just yesterday, on the 3rd of November, 41,299 positive cases were reported, along with 217 deaths and more than 141,000 people having lost their lives to the virus.
However, the new pill is meant to crack down on COVID-19 for those recently tested positive. Molnupiravir, which was developed by US drug company Merck, is the first oral antiviral medication for COVID-19, BBC News reports. It will be given twice a day for 5 days to patients over the age of 18. The pill allegedly cut the risk of hospitalisations or deaths by half among patients with early symptoms.
Health Secretary Sajid Javid said that today is a historic day for the UK, as it is the first country in the world to approve an antiviral which can also be taken at home to combat COVID-19. ‘We are working at pace across the government and with the NHS to set out plans to deploy molnupiravir to patients through a national study as soon as possible.’ What do you make of this?
#MaltaDaily